Big Rock Partners Acquisition in an 8-K filing today disclosed it is at risk of being delisted from the Nasdaq. The SPAC was notified in November that it was no longer in compliance with the listing rule because it had not completed a business combination within 36 months of its registration.
Big Rock said it was notified by Nasdaq last week that its failure to hold a shareholders’ meeting in fiscal 2020 could serve as an additional basis for delisting.
The SPAC has a $500 million merger agreement with NeuroRx, announced in December. Big Rock in the latest filing said it is working “with all due haste” to complete the merger. Read more.
